Lista de obras -

A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies.

artículo científico publicado en 2015

An approach to differential diagnosis of antiphospholipid antibody syndrome and related conditions

artículo científico publicado en 2014

Behçet's syndrome pathophysiology and potential therapeutic targets

artículo científico

Behçet's syndrome patients exhibit specific microbiome signature

artículo científico publicado en 2014

Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study

artículo científico publicado en 2017

Cytotoxic Th1 and Th17 cells infiltrate the intestinal mucosa of Behcet patients and exhibit high levels of TNF-α in early phases of the disease

artículo científico publicado en 2016

Favorable pregnancy outcome in a patient with systemic lupus erythematosus treated with belimumab: A confirmation report

artículo científico publicado en 2016

Lobular panniculitis with small vessel vasculitis associated with ulcerative colitis ⬇️

artículo científico publicado el 20 de febrero de 2011

Long-term efficacy and safety of anakinra in a patient with Behçet's disease and concomitant tuberculosis infection

artículo científico publicado en 2016

Microparticles: Bridging the Gap between Autoimmunity and Thrombosis

artículo científico

Neutrophil Activation Promotes Fibrinogen Oxidation and Thrombus Formation in Behçet Disease.

artículo científico publicado en 2015

Pulmonary fibrosis and lymphocytic alveolitis associated with triple antiphospholipid antibody positivity: a diagnostic puzzle.

artículo científico publicado en 2012

Reply: anti-IL1 blocking agents in drug-resistant Behçet's syndrome: our little case series

The "multifaceted" onset of vasculitis neuropathy

artículo científico publicado en 2012

Thrombosis in Autoimmune Diseases: A Role for Immunosuppressive Treatments?

artículo científico publicado en 2016

Thrombosis in vasculitis: from pathogenesis to treatment

artículo científico publicado en 2015

Tocilizumab-induced exacerbation of mucosal ulcers in a patient with multi-refractory Behçet׳s disease

scientific article published on 16 March 2016

β2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome

artículo científico publicado en 2017

Lista de obras de

A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies.

An approach to differential diagnosis of antiphospholipid antibody syndrome and related conditions

Behçet's syndrome pathophysiology and potential therapeutic targets

Behçet's syndrome patients exhibit specific microbiome signature

Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study

Cytotoxic Th1 and Th17 cells infiltrate the intestinal mucosa of Behcet patients and exhibit high levels of TNF-α in early phases of the disease

Favorable pregnancy outcome in a patient with systemic lupus erythematosus treated with belimumab: A confirmation report

Lobular panniculitis with small vessel vasculitis associated with ulcerative colitis ⬇️

Long-term efficacy and safety of anakinra in a patient with Behçet's disease and concomitant tuberculosis infection

Microparticles: Bridging the Gap between Autoimmunity and Thrombosis

Neutrophil Activation Promotes Fibrinogen Oxidation and Thrombus Formation in Behçet Disease.

Pulmonary fibrosis and lymphocytic alveolitis associated with triple antiphospholipid antibody positivity: a diagnostic puzzle.

Reply: anti-IL1 blocking agents in drug-resistant Behçet's syndrome: our little case series

The "multifaceted" onset of vasculitis neuropathy

Thrombosis in Autoimmune Diseases: A Role for Immunosuppressive Treatments?

Thrombosis in vasculitis: from pathogenesis to treatment

Tocilizumab-induced exacerbation of mucosal ulcers in a patient with multi-refractory Behçet׳s disease

β2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome